These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 37498052)

  • 1. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.
    Huang Z; Li Y; Park H; Ho M; Bhardwaj K; Sugimura N; Lee HW; Meng H; Ebert MP; Chao K; Burgermeister E; Bhatt AP; Shetty SA; Li K; Wen W; Zuo T
    Gut Microbes; 2023; 15(1):2237645. PubMed ID: 37498052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases.
    Noce A; Marrone G; Di Daniele F; Ottaviani E; Wilson Jones G; Bernini R; Romani A; Rovella V
    Nutrients; 2019 May; 11(5):. PubMed ID: 31091761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment.
    Shi J; Wang Y; Cheng L; Wang J; Raghavan V
    Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
    Ciernikova S; Sevcikova A; Drgona L; Mego M
    Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases?
    Amedei A; Capasso C; Nannini G; Supuran CT
    Mediators Inflamm; 2021; 2021():6926082. PubMed ID: 34803517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
    Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
    Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Microbiome and Antibiotics in Autoimmune Diseases.
    Vangoitsenhoven R; Cresci GAM
    Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
    Kapoor B; Gulati M; Gupta R; Singla RK
    Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome-based strategies for host health and disease.
    Wang C; Bai J; Chen X; Song J; Zhang Y; Wang H; Suo H
    Crit Rev Food Sci Nutr; 2024; 64(19):6834-6849. PubMed ID: 36803092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.